Ascendant Resources Inc (TSE:ASND) Director Mark Peter Brennan acquired 37,500 shares of the business’s stock in a transaction that occurred on Monday, June 19th. The stock was purchased at an average cost of C$0.60 per share, with a total value of C$22,500.00.

Mark Peter Brennan also recently made the following trade(s):

  • On Thursday, June 15th, Mark Peter Brennan purchased 1,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.60 per share, with a total value of C$600.00.
  • On Tuesday, May 16th, Mark Peter Brennan purchased 25,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.75 per share, with a total value of C$18,750.00.
  • On Wednesday, May 10th, Mark Peter Brennan purchased 22,500 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.73 per share, with a total value of C$16,425.00.
  • On Monday, May 1st, Mark Peter Brennan purchased 6,500 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.67 per share, with a total value of C$4,355.00.
  • On Tuesday, May 2nd, Mark Peter Brennan purchased 4,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.67 per share, with a total value of C$2,680.00.
  • On Thursday, April 27th, Mark Peter Brennan purchased 50,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.70 per share, with a total value of C$35,000.00.
  • On Wednesday, April 26th, Mark Peter Brennan purchased 38,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.65 per share, with a total value of C$24,700.00.
  • On Tuesday, April 25th, Mark Peter Brennan purchased 200,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.60 per share, with a total value of C$120,000.00.
  • On Wednesday, April 19th, Mark Peter Brennan purchased 287,000 shares of Ascendant Resources stock. The shares were bought at an average cost of C$0.63 per share, with a total value of C$180,810.00.

Insider Buying and Selling by Quarter for Ascendant Resources (TSE:ASND)

COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/06/19/insider-buying-ascendant-resources-inc-asnd-director-acquires-37500-shares-of-stock.html.

Ascendant Resources Company Profile

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone (TransCon hGH) for once-weekly administration to treat growth hormone deficiency (GHD) and other indications.

Receive News & Ratings for Ascendant Resources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascendant Resources Inc and related companies with MarketBeat.com's FREE daily email newsletter.